SCHEMBL11250319

SCHEMBL11250319

Cn1ccc(S)nc1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL439647 0.74
SCHEMBL27952255 0.73 PIK3CB (0.41)
SCHEMBL11582604 0.73
SCHEMBL20611026 0.73
SCHEMBL23128404 0.73
SCHEMBL25428969 0.73
SCHEMBL31227892 0.73
SCHEMBL1687064 0.72 SLC6A2 (0.31)
Iodide SCHEMBL29172953 0.71 PIK3CB (0.40)
Hydrochloric Acid SCHEMBL6853659 0.71 PIK3CB (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130149283-A1 METHODS AND COMPOSITIONS FOR TREATING HEPATITIS C VIRUS UNIVERSITA DEGLI STUDI DI CAGLIARI (IT) 2013-06-13 US disclosed
US-4348518-A Cephalosporins HOFFMANN-LA ROCHE INC. (US) 1982-09-07 US disclosed
US-4091211-A ANTIBIOTICS HOFFMANN-LA ROCHE INC. (US) 1978-05-23 US disclosed